shyam motors
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
-
Premium (ELP)
shyam motors's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of 48,10,000 Shares. The offering comprises a fresh issue component of 48,10,000 Shares.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on Sep 20, 2025 and will conclude on Sep 23, 2025. Following the subscription period, the share allotment is scheduled for Sep 24, 2025, with the official listing expected to commence on Sep 29, 2025 on the NSE exchange.
Incorporated in May 2005, Onyx Biotec Limited is a pharmaceutical company specializing in sterile water for injections and contract manufacturing of pharmaceutical products. The company operates two manufacturing units in Solan, Himachal Pradesh, with Unit I producing up to 638,889 units of sterile water injections daily and Unit II manufacturing 40,000 units of dry powder injections and 26,667 units of dry syrup per day. Serving both Indian and international markets, Onyx Biotec has built a diverse clientele, including major pharmaceutical names like Hetero Healthcare, Mankind Pharma, Sun Pharma, and Reliance Life Sciences, among over 100 clients as of May 31, 2024. The company is ISO 9001:2015 and ISO 14001:2015 certified, emphasizing quality and environmental management standards, and employs 175 people as of July 31, 2024.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium (GMP) is based on market buzz and unofficial trading. It should not be considered as the guaranteed listing price. Always refer to the RHP and seek advice from a financial expert before making investment decisions.
💡 Read our detailed guide: What is IPO Grey Market Premium (GMP) & How It Works?•📈 Track all live rates on IPO GMP Today
Expertise in Sterile Manufacturing: A leading contract manufacturer specializing in sterile products, ensuring high standards in production.
Quality Assurance and Control: Emphasis on rigorous quality assurance and control processes to maintain product safety and effectiveness.
Established Client Relationships: Long-term, strong relationships with a prestigious client base, reinforcing trust and repeat business.
Regional Concentration Risk: With all manufacturing units located in Solan, Himachal Pradesh, the company is vulnerable to regional economic, political, and natural disaster risks, which could disrupt operations.
Operational Disruptions: Any slowdown or shutdown in manufacturing could significantly impact business performance, financial condition, and cash flows.
Quality and Delivery Risks: Issues in manufacturing or quality control, or delays in product delivery, could lead to canceled orders, breached agreements, and loss of client trust, adversely affecting financial stability.
shyam motors
Bigshare Services Pvt Ltd